Virpax Pharmaceuticals, Inc. (VRPX)

NASDAQ: VRPX · IEX Real-Time Price · USD

0.530

+0.029 (5.81%)

At close: Jul 2, 2024, 4:00 PM

0.524

-0.006 (-1.15%)

After-hours: Jul 2, 2024, 6:50 PM EDT

Virpax Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	10.57	11.08	7.19	2.9	2.56	Upgrade
Research & Development	5.12	10.76	4.84	1.29	0.62	Upgrade
Operating Expenses	15.69	21.85	12.03	4.2	3.18	Upgrade
Operating Income	-15.69	-21.85	-12.03	-4.2	-3.18	Upgrade
Interest Expense / Income	0	0	0.09	0.15	0.12	Upgrade
Other Expense / Income	-0.5	-0.19	-0.06	-0	-	Upgrade
Pretax Income	-15.19	-21.65	-12.06	-4.34	-3.31	Upgrade
Net Income	-15.19	-21.65	-12.06	-4.34	-3.31	Upgrade
Shares Outstanding (Basic)	1	1	1	0	0	Upgrade
Shares Outstanding (Diluted)	1	1	1	0	0	Upgrade
Shares Change	0.02%	75.37%	114.88%	6.09%	3.18%	Upgrade
EPS (Basic)	-12.97	-18.49	-18.10	-14.00	-11.30	Upgrade
EPS (Diluted)	-12.97	-18.49	-18.10	-14.00	-11.30	Upgrade
Free Cash Flow	-9.85	-17.85	-14.54	-1.38	-1.13	Upgrade
Free Cash Flow Per Share	-8.41	-15.24	-21.78	-4.46	-3.86	Upgrade
EBITDA	-15.19	-21.65	-11.96	-4.19	-3.18	Upgrade
EBIT	-15.19	-21.65	-11.96	-4.19	-3.18	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).